These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 21453249)

  • 21. Recent advances in ophthalmic preparations: Ocular barriers, dosage forms and routes of administration.
    Maulvi FA; Shetty KH; Desai DT; Shah DO; Willcox MDP
    Int J Pharm; 2021 Oct; 608():121105. PubMed ID: 34537269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ophthalmic drug dosage forms: characterisation and research methods.
    Baranowski P; Karolewicz B; Gajda M; Pluta J
    ScientificWorldJournal; 2014; 2014():861904. PubMed ID: 24772038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimally invasive microneedles for ocular drug delivery.
    Thakur Singh RR; Tekko I; McAvoy K; McMillan H; Jones D; Donnelly RF
    Expert Opin Drug Deliv; 2017 Apr; 14(4):525-537. PubMed ID: 27485251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current and future ophthalmic drug delivery systems. A shift to the posterior segment.
    Del Amo EM; Urtti A
    Drug Discov Today; 2008 Feb; 13(3-4):135-43. PubMed ID: 18275911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liposomes as vehicles for topical ophthalmic drug delivery and ocular surface protection.
    López-Cano JJ; González-Cela-Casamayor MA; Andrés-Guerrero V; Herrero-Vanrell R; Molina-Martínez IT
    Expert Opin Drug Deliv; 2021 Jul; 18(7):819-847. PubMed ID: 33412914
    [No Abstract]   [Full Text] [Related]  

  • 26. Topical drug delivery devices: A review.
    Bertens CJF; Gijs M; van den Biggelaar FJHM; Nuijts RMMA
    Exp Eye Res; 2018 Mar; 168():149-160. PubMed ID: 29352994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent Advances in Topical Ocular Drug Delivery.
    Yellepeddi VK; Palakurthi S
    J Ocul Pharmacol Ther; 2016 Mar; 32(2):67-82. PubMed ID: 26666398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ocular delivery systems for topical application of anti-infective agents.
    Duxfield L; Sultana R; Wang R; Englebretsen V; Deo S; Rupenthal ID; Al-Kassas R
    Drug Dev Ind Pharm; 2016 Jan; 42(1):1-11. PubMed ID: 26325119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Newer approaches for optimal bioavailability of ocularly delivered drugs: review.
    Kesavan K; Balasubramaniam J; Kant S; Singh PN; Pandit JK
    Curr Drug Deliv; 2011 Mar; 8(2):172-93. PubMed ID: 21235476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In situ gelling systems for ocular drug delivery.
    Ahmed B; Jaiswal S; Naryal S; Shah RM; Alany RG; Kaur IP
    J Control Release; 2024 Jul; 371():67-84. PubMed ID: 38768662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug delivery to the posterior segment of the eye.
    Fischer N; Narayanan R; Loewenstein A; Kuppermann BD
    Eur J Ophthalmol; 2011; 21 Suppl 6():S20-6. PubMed ID: 23264325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ocular drug delivery.
    Ghate D; Edelhauser HF
    Expert Opin Drug Deliv; 2006 Mar; 3(2):275-87. PubMed ID: 16506953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug delivery to the back of the eye following topical administration: an update on research and patenting activity.
    Boddu SH; Gupta H; Patel S
    Recent Pat Drug Deliv Formul; 2014 Apr; 8(1):27-36. PubMed ID: 24475918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Episcleral, intrascleral, and suprachoroidal routes of ocular drug delivery - recent research advances and patents.
    Gilger BC; Mandal A; Shah S; Mitra AK
    Recent Pat Drug Deliv Formul; 2014; 8(2):81-91. PubMed ID: 25001638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Applications of poloxamers in ophthalmic pharmaceutical formulations: an overview.
    Almeida H; Amaral MH; Lobão P; Sousa Lobo JM
    Expert Opin Drug Deliv; 2013 Sep; 10(9):1223-37. PubMed ID: 23688342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclosporine A delivery to the eye: A comprehensive review of academic and industrial efforts.
    Lallemand F; Schmitt M; Bourges JL; Gurny R; Benita S; Garrigue JS
    Eur J Pharm Biopharm; 2017 Aug; 117():14-28. PubMed ID: 28315447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in topical nano drug-delivery systems for the anterior ocular segment.
    Lakhani P; Patil A; Majumdar S
    Ther Deliv; 2018 Feb; 9(2):137-153. PubMed ID: 29325511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ocular drugs and drug delivery systems - Current trends and future perspectives.
    Rupenthal ID; Daugherty AL
    Drug Discov Today; 2019 Aug; 24(8):1425-1426. PubMed ID: 31330186
    [No Abstract]   [Full Text] [Related]  

  • 39. [Ocular pharmacology in the treatment of vitreous, retina and choroid diseases].
    Filho PA; Maia M; Rodrigues EB; Farah ME
    Arq Bras Oftalmol; 2010; 73(3):294-9. PubMed ID: 20730292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanoformulations for Ocular Delivery of Drugs - A Patent Perspective.
    Dogra A; Kaur K; Ali J; Baboota S; Narang RS; Narang JK
    Recent Pat Drug Deliv Formul; 2019; 13(4):255-272. PubMed ID: 31985387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.